Cargando…

New tools to diagnose and follow FAC patients: biomarkers

Detalles Bibliográficos
Autor principal:	Merlini, Giampaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642095/ http://dx.doi.org/10.1186/1750-1172-10-S1-I16

Ejemplares similares

Cardiologic Phenotypes and Natural History of FAC
por: Rapezzi, Claudio
Publicado: (2015)

Integrated OMICS tools for personalised medicine
por: Borro, Marina, et al.
Publicado: (2015)

Discussion session: biomarker trials
Publicado: (2015)

Using biomarkers prospectively in adaptive clinical trials
por: Berry, Donald A
Publicado: (2011)

S48. Biomarker development for ipilimumab and prostate GVAX treatment
por: de Gruijl, T, et al.
Publicado: (2014)

Is lack of habituation a biomarker of migraine? A critical perspective
por: Brighina, Filippo, et al.
Publicado: (2015)

Follow-up management and the management of high versus low risk patients in primary care
por: Flokstra, Bertine
Publicado: (2011)

New antiretrovirals
por: Gulick, Roy
Publicado: (2012)

Controversies about the role of the deficit of habituation of evoked potentials in migraine: a disease biomarker? PROS
por: Ambrosini, Anna
Publicado: (2015)

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
por: Cha, E
Publicado: (2014)

Type 1 diabetes - an auto-inflammatory disease: a new concept, new therapeutical strategies
por: Limbert, Catarina
Publicado: (2012)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

Diffusion of new antiretroviral drugs in CSF
por: Aweeka, Francesca
Publicado: (2010)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

What is new in the treatment of eosinophilic eosophagitis?
por: Assa'ad, Amal
Publicado: (2011)

PReS13-SPK-1350: Autoimmune responses following vaccination in healthy populations
por: Toplak, N
Publicado: (2013)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

New medicines to improve control and contribute to the eradication of malaria
por: Wells, Timothy NC
Publicado: (2010)

Retroviral restriction factors: new mechanisms of innate immunity
por: Wolf, Daniel, et al.
Publicado: (2009)

Finding new immune regulatory genes by ENU mutagenesis
por: Enders, Anselm, et al.
Publicado: (2012)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

Use of new technologies to detect and understand HIV drug resistance
por: Kozal, Michael J
Publicado: (2010)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

New perspectives on immunological pathways underlying peanut-induced anaphylaxis
por: Jordana, Manel
Publicado: (2011)

PReS13-SPK-1240: New aspects on APS pathogenesis
por: Meroni, PL
Publicado: (2013)

Impact of a new European regulations on functional food market – an overview
por: Lovik, Martinus
Publicado: (2011)

PReS13-SPK-1034: looking for new monogenic forms of lupus
por: Crow, Y
Publicado: (2013)

Food allergen protein families and their structural characteristics: new data from Europrevail
por: Hoffmann-Sommergruber, Karin
Publicado: (2011)

PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA
por: Livermore, P
Publicado: (2013)

PReS13-SPK-1137: New developments in our care & understanding of JIA
por: Beresford, MW
Publicado: (2013)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome
por: Van den Steen, Philippe E, et al.
Publicado: (2010)

PReS13-SPK-1587: New biologic targets for the future and basic science behind them
por: Prakken, B
Publicado: (2013)

PReS13-SPK-1408: New EU scientific guidelines for JIA, SLE and GIOP from the European Medicines Agency
por: Vesely, R
Publicado: (2013)

Cortical modulation of thalamic function during cortical spreading depression- Unraveling a new central mechanism involved in migraine aura"
por: Andreou, Anna P, et al.
Publicado: (2013)

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014)

The patient’s perspective on precautionary labelling
por: DunnGalvin, Audrey
Publicado: (2011)

Osmophobia in adult and juvenile headache patients
por: Zanchin, Giorgio
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fjj692td5ifm7ft1g6tk93q41q